Author

Martin Müller

MODELLING JOHANSON-BLIZZARD SYNDROME IN A DISH
MODELLING JOHANSON-BLIZZARD SYNDROME IN A DISH

ENDOFUTURE-STRATEGIES FROM CIVIL AVIATION FOR OPTIMIZED TEAMWORK AND COMMUNICATION IN INTERVENTIONAL ENDOSCOPY
ENDOFUTURE-STRATEGIES FROM CIVIL AVIATION FOR OPTIMIZED TEAMWORK AND COMMUNICATION IN INTERVENTIONAL ENDOSCOPY

Martin Müller  et al.

TRANSGASTRAL ENDOSCOPIC DRAINAGE OF PANCREATIC PSEUDOCYSTS AND WALLED-OFF NECROSIS - A DETAILED GLANCE AT PERIPROCEDURAL ADVERSE EVENTS AND SUPERINFECTION
TRANSGASTRAL ENDOSCOPIC DRAINAGE OF PANCREATIC PSEUDOCYSTS AND WALLED-OFF NECROSIS - A DETAILED GLANCE AT PERIPROCEDURAL ADVERSE EVENTS AND SUPERINFECTION

Martin Müller  et al.

MODELLING JOHANSON-BLIZZARD SYNDROME IN A DISH
MODELLING JOHANSON-BLIZZARD SYNDROME IN A DISH

Martin Müller  et al.

EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?
EZH2, AN EPIGENETIC FACTOR INVOLVED IN ONCOGENIC PROPERTIES OF ATM DEFICIENT PDAC SUBTYPES?

Martin Müller  et al.

EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK
EXPLORING ROLES OF ATM-DELETION IN PANCREATIC CANCER VULNERABILITIES AND CANCER-ASSOCIATED FIBROBLAST/TUMOR CELL CROSSTALK

Martin Müller  et al.

A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE
A PROSPECTIVE FEASIBILITY TRIAL TO CHALLENGE PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS IN PREDICTING TREATMENT RESPONSE

Martin Müller  et al.

LONG TERM RESPONSE TO RITUXIMAB IN PATIENTS WITH TYPE 1 AUTOIMMUNE PANCREATITIS
LONG TERM RESPONSE TO RITUXIMAB IN PATIENTS WITH TYPE 1 AUTOIMMUNE PANCREATITIS

Martin Müller  et al.

SARS-COV-2 INFECTION OF THE INTESTINAL TRACT MODELLED IN HUMAN PLURIPOTENT STEM CELL-DERIVED INTESTINAL ORGANOIDS
SARS-COV-2 INFECTION OF THE INTESTINAL TRACT MODELLED IN HUMAN PLURIPOTENT STEM CELL-DERIVED INTESTINAL ORGANOIDS

Martin Müller  et al.

MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY
MAINTENANCE THERAPY FOR ATM-DEFICIENT PANCREATIC CANCER BY MULTIPLE DNA REPAIR PATHWAY INHIBITION AFTER PLATINUM-BASED CHEMOTHERAPY

Martin Müller  et al.

PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER
PARP INHIBITOR RESISTANCE INDUCES MASSIVE GENOME ALTERATIONS RESPONSIBLE OF THE ACQUISITION OF MULTIDRUG RESISTANCE IN DNA DAMAGE REPAIR-DEFICIENT PANCREATIC CANCER

Martin Müller  et al.

HNF6 IN HUMAN PANCREATIC DUCT DEVELOPMENT
HNF6 IN HUMAN PANCREATIC DUCT DEVELOPMENT

Martin Müller  et al.

KRAS ACTIVATION IN THE CONTEXT OF BRCA2 DEFICIENCY DRIVES DEDIFFERENTIATION OF DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
KRAS ACTIVATION IN THE CONTEXT OF BRCA2 DEFICIENCY DRIVES DEDIFFERENTIATION OF DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

Martin Müller  et al.

SERUM IGG4 LEVELS OUTPERFORM IGG4/IGG RNA RATIO IN DIFFERENTIAL DIAGNOSIS OF IGG4-RELATED DISEASE
SERUM IGG4 LEVELS OUTPERFORM IGG4/IGG RNA RATIO IN DIFFERENTIAL DIAGNOSIS OF IGG4-RELATED DISEASE

Martin Müller  et al.

MCCUNE-ALBRIGHT SYNDROME AND IPMN FORMATION MODELLED IN GNAS-MUTATED DUCT-LIKE ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
MCCUNE-ALBRIGHT SYNDROME AND IPMN FORMATION MODELLED IN GNAS-MUTATED DUCT-LIKE ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

Martin Müller  et al.

PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS AS A PERSONALIZED PRECLINICAL TOOL FOR DRUG RESPONSE PREDICTION
PATIENT-DERIVED PANCREATIC CANCER ORGANOIDS AS A PERSONALIZED PRECLINICAL TOOL FOR DRUG RESPONSE PREDICTION

Martin Müller  et al.

MODELLING PLASTICITY AND DYSPLASIA OF PANCREATIC DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS
MODELLING PLASTICITY AND DYSPLASIA OF PANCREATIC DUCTAL ORGANOIDS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

Martin Müller  et al.

Item 1 - 17 / 17
1